RT Journal Article
SR Electronic
T1 BMI Interacts with the Genome to Regulate Gene Expression Globally, with Emphasis in the Brain and Gut
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.11.26.24317923
DO 10.1101/2024.11.26.24317923
A1 Signer, Rebecca
A1 Seah, Carina
A1 Young, Hannah
A1 Retallick-Townsley, Kayla
A1 Pins, Agathe De
A1 Cote, Alanna
A1 Lee, Seoyeon
A1 Jia, Meng
A1 Johnson, Jessica
A1 Johnston, Keira J. A.
A1 Xu, Jiayi
A1 Brennand, Kristen J.
A1 Huckins, Laura M.
YR 2024
UL http://medrxiv.org/content/early/2024/11/28/2024.11.26.24317923.abstract
AB Genome-wide association studies identify common genomic variants associated with disease across a population. Individual environmental effects are often not included, despite evidence that environment mediates genomic regulation of higher order biology. Body mass index (BMI) is associated with complex disorders across clinical specialties, yet has not been modeled as a genomic environment. Here, we tested for expression quantitative trait (eQTL) loci that contextually regulate gene expression across the BMI spectrum using an interaction approach. We parsed the impact of cell type, enhancer interactions, and created novel BMI-dynamic gene expression predictor models. We found that BMI main effects associated with endocrine gene expression, while interactive variant-by-BMI effects impacted gene expression in the brain and gut. Cortical BMI-dynamic loci were experimentally dysregulated by inflammatory cytokines in an in vitro system. Using BMI-dynamic models, we identify novel genes in nitric oxide signaling pathways in the nucleus accumbens significantly associated with depression and smoking. While neither genetics nor BMI are sufficient as standalone measures to capture the complexity of downstream cellular consequences, including environment powers disease gene discovery.Competing Interest StatementThe authors have declared no competing interest.Funding StatementLMH acknowledges funding from NIMH (R01MH124839, R01MH118278, R01MH125938, RM1MH132648, R01MH136149), NIEHS (R01ES033630), and the Department of Defense (TP220451).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study used only publicly available data.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors